For more information or confidential assistance
Call 800-306-3180

Fifth Risperdal Case Ends in Settlement before Trial

Risperdal Lawsuit
The most recent Risperdal lawsuit slated to go before a jury ended in a settlement before the trial even began. Risperdal manufacturer Johnson & Johnson agreed to settle the case for an undisclosed amount, possibly avoiding another massive judgement that has characterized recent Risperdal trials. The latest case, which was... Read More

Risperdal Linked to Childhood Diabetes

In the heat of debate over how antipsychotic prescriptions may impact the health of children, a new study solidifies the link between the medications and diabetes. The medical journal JAMA Psychiatry released the report of the study late last month and the results indicate that... Read More

Report: FDA Lacks Sufficient Data Regarding Drug Safety

The U.S. Government Accountability Office (GAO) has released a report to the Subcommittee on Labor, Health, and Human Services of the House of Representatives detailing what it calls “problems with (the FDA’s) postmarket safety data.” The GAO report claims that the FDA “lacks reliable, readily... Read More